tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CSPC Pharmaceutical’s Semaglutide Injection Gains NMPA Approval for Diabetes Treatment
Company AnnouncementsCSPC Pharmaceutical’s Semaglutide Injection Gains NMPA Approval for Diabetes Treatment
1d ago
CSPC Pharmaceutical Partners with Madrigal for Global Expansion of Diabetes Drug
PremiumCompany Announcements
CSPC Pharmaceutical Partners with Madrigal for Global Expansion of Diabetes Drug
7d ago
CSPC Pharmaceutical’s Mesalazine Tablets Gain Approval in China
PremiumCompany Announcements
CSPC Pharmaceutical’s Mesalazine Tablets Gain Approval in China
1M ago
CSPC Pharmaceutical Gains Approval for MMA Treatment Trials in China
PremiumCompany Announcements
CSPC Pharmaceutical Gains Approval for MMA Treatment Trials in China
1M ago
CSPC Pharmaceutical Group Enhances Nomination Committee with New Appointment
PremiumCompany Announcements
CSPC Pharmaceutical Group Enhances Nomination Committee with New Appointment
1M ago
CSPC Pharmaceutical Group Announces Board Composition
PremiumCompany AnnouncementsCSPC Pharmaceutical Group Announces Board Composition
1M ago
CSPC Pharmaceutical Group Updates Nomination Committee Terms
Premium
Company Announcements
CSPC Pharmaceutical Group Updates Nomination Committee Terms
1M ago
CSPC Pharmaceutical Group Renews Lease Agreements Amid Regulatory Compliance
Premium
Company Announcements
CSPC Pharmaceutical Group Renews Lease Agreements Amid Regulatory Compliance
1M ago
CSPC Pharmaceutical’s Meloxicam Injection Approved in China
PremiumCompany Announcements
CSPC Pharmaceutical’s Meloxicam Injection Approved in China
1M ago
CSPC Pharmaceutical Group Partners with AstraZeneca for AI-Driven Drug Discovery
PremiumCompany Announcements
CSPC Pharmaceutical Group Partners with AstraZeneca for AI-Driven Drug Discovery
2M ago
CSPC Pharmaceutical Gains U.S. FDA Approval for Cancer Drug Trial
PremiumCompany Announcements
CSPC Pharmaceutical Gains U.S. FDA Approval for Cancer Drug Trial
2M ago
CSPC Pharmaceutical’s Cobamamide Capsules Gain Approval in China
PremiumCompany Announcements
CSPC Pharmaceutical’s Cobamamide Capsules Gain Approval in China
2M ago
CSPC’s JMT101 Receives Breakthrough Therapy Designation in China
PremiumCompany AnnouncementsCSPC’s JMT101 Receives Breakthrough Therapy Designation in China
2M ago
CSPC Pharmaceutical Group’s AGM Resolutions Passed Successfully
Premium
Company Announcements
CSPC Pharmaceutical Group’s AGM Resolutions Passed Successfully
2M ago
CSPC Pharmaceutical Group Reports Q1 2025 Earnings
Premium
Company Announcements
CSPC Pharmaceutical Group Reports Q1 2025 Earnings
2M ago
CSPC Pharmaceutical Group in Talks for Major Licensing Deals
PremiumCompany Announcements
CSPC Pharmaceutical Group in Talks for Major Licensing Deals
2M ago
CSPC Pharmaceutical Group Reports Decline in Q1 2025 Results Amid Industry Challenges
PremiumCompany Announcements
CSPC Pharmaceutical Group Reports Decline in Q1 2025 Results Amid Industry Challenges
2M ago
CSPC Pharmaceutical’s JMT106 Gains Clinical Trial Approval in China
PremiumCompany Announcements
CSPC Pharmaceutical’s JMT106 Gains Clinical Trial Approval in China
3M ago
CSPC’s CPO301 Receives Third FDA Fast Track Designation
PremiumCompany Announcements
CSPC’s CPO301 Receives Third FDA Fast Track Designation
3M ago
CSPC Pharmaceutical Group Schedules Board Meeting for Quarterly Results
PremiumCompany AnnouncementsCSPC Pharmaceutical Group Schedules Board Meeting for Quarterly Results
3M ago
CSPC Pharmaceutical Partners with Cipla USA for U.S. Market Expansion
Premium
Company Announcements
CSPC Pharmaceutical Partners with Cipla USA for U.S. Market Expansion
3M ago
CSPC Pharmaceutical Group’s New Drug Approval Enhances Digestive Treatment Portfolio
Premium
Company Announcements
CSPC Pharmaceutical Group’s New Drug Approval Enhances Digestive Treatment Portfolio
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >